MX2017006892A - Polyvalent, highly immunogenic subunit vaccine against mastitis in mammals. - Google Patents

Polyvalent, highly immunogenic subunit vaccine against mastitis in mammals.

Info

Publication number
MX2017006892A
MX2017006892A MX2017006892A MX2017006892A MX2017006892A MX 2017006892 A MX2017006892 A MX 2017006892A MX 2017006892 A MX2017006892 A MX 2017006892A MX 2017006892 A MX2017006892 A MX 2017006892A MX 2017006892 A MX2017006892 A MX 2017006892A
Authority
MX
Mexico
Prior art keywords
polyvalent
mammals
vaccine against
subunit vaccine
highly immunogenic
Prior art date
Application number
MX2017006892A
Other languages
Spanish (es)
Inventor
Nicole LAPIERRE ACEVEDO Lisette
Enrique SÁENZ ITURRIAGA Leonardo
Original Assignee
Univ Chile
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Chile filed Critical Univ Chile
Publication of MX2017006892A publication Critical patent/MX2017006892A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to a polyvalent, highly immunogenic subunit vaccine against mastitis in mammals, made of a formulation comprising a mixture of fragments of cell wall and membranes and small liposomes from the cell membrane of the pathogens selected from Staphylococcus aureus, Escherichia coli and Streptococcus uberis, where said fragments of cell wall and membranes release immunostimulant intracellular elements such as membrane proteins, lipopolysaccharide, peptidoglycan, exopolysaccharides.
MX2017006892A 2014-11-28 2015-11-25 Polyvalent, highly immunogenic subunit vaccine against mastitis in mammals. MX2017006892A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CL2014003247A CL2014003247A1 (en) 2014-11-28 2014-11-28 Subunit vaccine, polyvalent against mastitis in mammals, comprising cell wall and membrane fragments of pathogens selected from staphylococcus aureus, escherichia coli and streptococcus uberis; preparation procedure; and use to immunogenize a mammal.
PCT/CL2015/050046 WO2016082054A1 (en) 2014-11-28 2015-11-25 Polyvalent, highly immunogenic subunit vaccine against mastitis in mammals

Publications (1)

Publication Number Publication Date
MX2017006892A true MX2017006892A (en) 2018-01-23

Family

ID=56073267

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017006892A MX2017006892A (en) 2014-11-28 2015-11-25 Polyvalent, highly immunogenic subunit vaccine against mastitis in mammals.

Country Status (5)

Country Link
BR (1) BR112017011292B1 (en)
CL (1) CL2014003247A1 (en)
CO (1) CO2017005389A2 (en)
MX (1) MX2017006892A (en)
WO (1) WO2016082054A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024072985A1 (en) * 2022-09-28 2024-04-04 University Of Tennessee Research Foundation Polyvalent vaccines for staphylococcal & streptococcal infection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011018858A1 (en) * 2009-08-14 2011-02-17 エヌエーアイ株式会社 Novel mastitis vaccine

Also Published As

Publication number Publication date
CL2014003247A1 (en) 2015-07-10
CO2017005389A2 (en) 2017-07-19
BR112017011292B1 (en) 2024-01-16
WO2016082054A1 (en) 2016-06-02
BR112017011292A2 (en) 2017-12-26
WO2016082054A9 (en) 2016-06-23

Similar Documents

Publication Publication Date Title
EP3600400A4 (en) A multiple antigen presenting system (maps)-based staphylococcus aureus vaccine, immunogenic composition, and uses thereof
WO2018089851A3 (en) Influenza vaccine
TR201908550T4 (en) Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications.
WO2016019134A8 (en) Flagellin-based agents and uses including effective vaccination
BR112016024644A2 (en) nucleic acid vaccines
EA201691478A1 (en) NEW POLYSACCHARIDE AND ITS APPLICATIONS
WO2015044337A3 (en) Dry formulations of vaccines that are room temperature stable
EA201892568A1 (en) METHODS OF OBTAINING CONTRAST FACILITIES FOR ULTRASONIC RESEARCH
ZA201608487B (en) Dual adjuvant vaccine compositions, preparation and uses
MY191539A (en) Streptococcal vaccine
PH12014502855A1 (en) Attenuated streptococcus suis vaccines and methods of making and use thereof
ZA201902563B (en) Expec glycoconjugate vaccine formulations
BR112018013932A2 (en) platelet preparation systems and methods
IL276661A (en) Immunogenic composition comprising staphylococcal antigens
EP4241851A3 (en) Immunogenic compositions
EP3903810A4 (en) Preparation including vaccine adjuvant
EA201792512A1 (en) COMPOSITIONS FOR DELIVERY OF ANTIGENS OF RESPIRATORY SYNTICIAL VIRUS AND NOROVIRUS INTO THE THIN INTESTINE
EP3747459A4 (en) Novel vaccine immunoadjuvant
EP3439693A4 (en) Novel pneumococcal vaccine formulations
MX2017006892A (en) Polyvalent, highly immunogenic subunit vaccine against mastitis in mammals.
WO2015149085A3 (en) Warer-soluble trans-membrane proteins and methods for the preparation and use thereof
MX2015013808A (en) Vaccine against rhipicephalus ticks.
EP3529260A4 (en) Vaccine constructs and uses thereof against staphylococcus infections
WO2016091890A3 (en) Meningitidis vaccines comprising subtilinases
EP3355910A4 (en) Aluminum based adjuvants for tolerogenic vaccination